BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Transplant. Dec 18, 2025; 15(4): 111031
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.111031
Table 1 Overall recipient and donor characteristics, n (%)

Mean
SD
Median
Interquartile range
Frequency
Recipient age47.313.74819
Recipient HTN4 (2.7)
Recipient atheroma12 (8.1)
Recipient DM21 (14.1)
Recipient BMI (kg/m2)27.12.95274
Donor age47.712.34819
Donor HTN1 (0.7)
Donor atheroma2 (1.3)
Donor DM9 (6)
Donor BMI (kg/m2)27.74.57274.57
Donor baseline estimated glomerular filtration rate900
Table 2 Perioperative characteristics of living donor kidney transplantation. mean cold ischaemic time (from time of kidney perfused with hypothermic perfusion solution to time out of ice), n (%)
Maintenance immunosuppression

Tacrolimus78 (53)
Tacrolimus + mycophenolate32 (21.4)
Tacrolimus + prednisolone + mycophenolate25 (16.8)
Tacrolimus + prednisolone12 (8.1)
Mismatch category (National Health Service Blood and Transplant)
117 (11.4)
218 (12.1)
367 (45)
447 (31.5)
Cold ischaemia time (minutes) (mean ± SD)251 ± 104
Vascular anatomy
Single118 (79.2)
Multiple24 (16.1)
Reconstruction7 (4.7)
Modality of donor nephrectomy
Mini open24 (16.1)
Hand-assisted retroperitoneoscopic42 (28.1)
Laparoscopic (including, hand-assisted)83 (55.7)
Table 3 Overall recipient outcomes, n (%)
Classification
Frequency
Length of stay7 (2)
Delayed graft function1 (0.67)
Perioperative bleeding7 (5.6)
Surgical site infection6 (4)
Overall incisional hernia11 (7.4)
Death with a functioning graft3 (2)
Return to dialysis9 (6)
Time to return to dialysis43.1 ± 12.1
1-year recipient survival99.3
3-year recipient survival96.4
5-year recipient survival94.6
1-year graft survival99.3
3-year graft survival97.2
5-year graft survival90.4
1-year recipient eGFR59.2 ± 16.3
3-year recipient eGFR54.6 ± 19.9
5-year recipient eGFR52.1 ± 22.5
5-year rejection19 (17)
1-year donor eGFR67 (21.5)
3-year donor eGFR68 (21)
5-year donor eGFR70 (21)
Table 4 Donor and recipient outcomes for subgroup analysis post living donor kidney transplantation, n (%)

Group 1
Group 2
Group 3
Group 4
P value
Delayed graft function01000.398
Perioperative bleeding22120.615
Surgical site infection31110.941
Incisional hernia02320.227
1-year recipient survival10010097.51000.433
1-year graft survival10010097.51000.433
1-year recipient eGFR63.9 ± 15.355.9 ± 16.556.1 ± 14.658 ± 19.50.053
1-year donor eGFR67 (15.2)69 (14)67.6 (15.7)69.8 (14.2)0.834
3-year recipient survival98.19797.489.50.451
3-year graft survival98.1979090.90.383
3-year recipient eGFR60 ± 19.352.3 ± 20.252 ± 16.751 ± 22.60.136
3-year donor eGFR71.2 (15)71.8 (15)70 (14.7)67.6 (15.1)0.801
5-year recipient survival9792.885.382.40.170
5-year graft survival979686.782.30.143
5-year recipient eGFR57.8 ± 21.651.7 ± 21.550.4 ± 22.345 ± 25.50.270
5-year rejection9 (26.5)3 (10.7)6 (18.2)1 (5.9)0.247
5-year donor eGFR70 (17.2)71.7 (14.3)72 (16)72 (12)0.568
Table 5 Linear regression analysis model for 5-year graft function
Predictor
β
SE
P value
5-year patient survival24.6117.960.174
Return to dialysis-41.376.440.001
Rejection-14.314.940.005
Subgroup comparisons
1 and 2-6.304.770.189
1-3-4.254.570.354
1-4-11.805.580.037
Intercept38.2518.230.038